BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1285251)

  • 1. The role of fibrin fibrils in the dissociation of a cell surface protease-inhibitor complex and evidence for the recapture of the inhibitor protein.
    Steven FS; Blakey DC
    J Enzyme Inhib; 1992; 5(4):299-315. PubMed ID: 1285251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association and dissociation of a protease and its inhibitor on the surface of lung squamous cell carcinoma cells.
    Steven FS; Anees M; Myers J; Hasleton P
    Anticancer Res; 1993; 13(4):1063-8. PubMed ID: 8352526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential competitive inhibition of a cell surface protease on normal epithelial cells and carcinoma cells of the colon.
    Steven FS; Anees M; Talbot IC
    Anticancer Res; 1994; 14(5A):2013-6. PubMed ID: 7847843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity preparation of a protein inhibitor recognising a cell surface protease.
    Steven FS; Griffin MM; Bell J; Talbot IC
    J Enzyme Inhib; 1993; 7(1):65-76. PubMed ID: 7510796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of the plasminogen activator inhibitor (PAI-1) for the iso enzyme of guanidinobenzoatase on the surface of colonic carcinoma cells.
    Steven FS; Anees M; Booth NA
    Anticancer Res; 1995; 15(1):205-10. PubMed ID: 7733635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the interaction and exchange of inhibitors and proteases on the surface of tumour cells in frozen sections.
    Steven FS; Griffin MM; Bulleid NJ; Maier H; Born IA
    Anticancer Res; 1991; 11(6):2117-22. PubMed ID: 1776849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of tissue plasminogen activator inhibitor with cell surface guanidinobenzoatase and urokinase plasminogen activator.
    Anees M
    J Enzyme Inhib; 1996; 10(4):281-8. PubMed ID: 8872748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for different isoenzymic forms of a cell surface protease, guanidinobenzoatase, associated with tumours.
    Steven FS; Griffin MM; Blakey DC; Talbot IC; Hanski C; Bell J
    Anticancer Res; 1992; 12(6B):2159-64. PubMed ID: 1295463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interactions of protein inhibitors with tumour proteases studied in solution and immobilised on cell surfaces in frozen sections.
    Steven FS; Anees M; Talbot IC; Blakey DC; Hasleton PS
    Anticancer Res; 1993; 13(6A):2003-10. PubMed ID: 8297107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for distinct isoenzymic forms of a cell surface protease on normal colonic cells and on carcinoma cells from the same colon.
    Steven FS; Griffin MM; Talbot IC
    Anticancer Res; 1991; 11(1):143-50. PubMed ID: 1708219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the functional similarity between tumour cell surface guanidinobenzoatase and tissue type plasminogen activator.
    Steven FS; Griffin MM; Cederholm-Williams SA; Mangel WF; Maier H
    Anticancer Res; 1991; 11(2):641-7. PubMed ID: 1905903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of a cell surface protease after cisplatin chemotherapy.
    Steven FS; Zoeller J; Maier H; Born IA
    J Enzyme Inhib; 1991; 5(2):151-64. PubMed ID: 1669443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent location of human colonic tumour cells by means of an enzyme-inhibitor complex.
    Steven FS; Maier H; Talbot IC
    J Enzyme Inhib; 1990; 3(3):229-36. PubMed ID: 2079640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GB (guanidinobenzoatase) cell surface protease and serum inhibitors in colorectal neoplasia.
    Steven FS; Griffin MM; Talbot IC
    J Pathol; 1992 May; 167(1):19-24. PubMed ID: 1625054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on the conformational changes in the structure of a cell surface protease, followed by its ability to be recognised by competitive and non-competitive inhibitors.
    Steven FS; Griffin MM; Anees M; Benbow EW
    J Enzyme Inhib; 1992; 6(3):251-8. PubMed ID: 1284962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitor reacting with a tumour cell surface protease can be exchanged with plasminogen activator inhibitor (PAI-1).
    Steven FS; Booth NA
    J Enzyme Inhib; 1991; 4(3):273-9. PubMed ID: 2037870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The targeting of agmatine-liganded mitomycin C to an enzyme on the surface of tumour cells.
    Steven FS; Griffin MM; Talbot IC
    Anticancer Res; 1990; 10(3):583-9. PubMed ID: 2114817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct evidence for the cell surface location of a protease-inhibitor complex on intact leukaemia cells.
    Steven FS; Griffin MM
    J Enzyme Inhib; 1990; 3(4):311-6. PubMed ID: 2319334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition of a tumour cell surface protease. A rapid technique for in vitro testing of selective targeting systems.
    Steven FS; Griffin MM; Barnett FB; Epenetos AA
    J Enzyme Inhib; 1990; 4(1):63-73. PubMed ID: 2094772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of tumour cells in colon tissue by Texas red labelled pentosan polysulphate, an inhibitor of a cell surface protease.
    Anees M
    J Enzyme Inhib; 1996; 10(3):203-14. PubMed ID: 8835946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.